TipRanks
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
US Market
SPRO
Spero Therapeutics
RESEARCH TOOLSreports
Want to see SPRO full AI Analyst Report?

Spero Therapeutics (SPRO) Stock Forecast & Price Target

604 Followers
See the Price Targets and Ratings of:

SPRO Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Spero
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SPRO Stock 12 Month Forecast

There Are No Analyst Ratings for SPRO In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SPRO Financial Forecast

SPRO Earnings Forecast

Next quarter’s earnings estimate for SPRO is -$0.14 with a range of -$0.14 to -$0.14. The previous quarter’s EPS was -$0.16. SPRO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SPRO has Performed in-line its overall industry.
Next quarter’s earnings estimate for SPRO is -$0.14 with a range of -$0.14 to -$0.14. The previous quarter’s EPS was -$0.16. SPRO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SPRO has Performed in-line its overall industry.

SPRO Sales Forecast

Next quarter’s sales forecast for SPRO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SPRO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SPRO has Performed in-line its overall industry.
Next quarter’s sales forecast for SPRO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SPRO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SPRO has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on SPRO
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$4
Hold
230.58%
Upside
Reiterated
12/17/25
Evercore ISI Keeps Their Hold Rating on Spero Therapeutics (SPRO)
TD Cowen Analyst forecast on SPRO
Ritu Baral
TD Cowen
TD Cowen
―
Hold
―
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Spero Therapeutics (NASDAQ: SPRO), Kodiak Sciences (NASDAQ: KOD) and VolitionRX (NYSE MKT: VNRX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on SPRO
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$4
Hold
230.58%
Upside
Reiterated
12/17/25
Evercore ISI Keeps Their Hold Rating on Spero Therapeutics (SPRO)
TD Cowen Analyst forecast on SPRO
Ritu Baral
TD Cowen
TD Cowen
―
Hold
―
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Spero Therapeutics (NASDAQ: SPRO), Kodiak Sciences (NASDAQ: KOD) and VolitionRX (NYSE MKT: VNRX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SPRO Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, SPRO has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SPRO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

SPRO Stock Forecast FAQ

What is SPRO’s average 12-month price target, according to analysts?
Currently, no data Available
What is SPRO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SPRO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SPRO a Buy, Sell or Hold?
      Currently, no data Available
      What is Spero Therapeutics Inc’s price target?
      Currently, no data Available
      What do analysts say about Spero Therapeutics Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SPRO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.